Franco Moscetti - DiaSorin SpA Independent Director

34D Stock  EUR 90.34  3.88  4.49%   

Director

Mr. Franco Moscetti has served as Independent Director of Diasorin S.p.A. since March 26, 2007. He also serves as Chairman of the Audit and of the Nominating Committees of the Company. He also serves as Coordinator of the Committee for Transactions with Related Parts within the Company. He started his professional career in 1973, at Air Liquide Group. In 1989, he was appointed General Manager at Vitalaire Italia. In 1995, was appointed as General Manager and Chief Executive Officer of Air Liquide Sanita. Currently, he serves as Director at Touring Club Italiano and Fideuram Investimenti SGR SpA and as Chief Executive Officer and General Manager of Amplifon SpA. since 2007.
Age 66
Tenure 17 years
Phone39 01 614871
Webhttps://diasoringroup.com

DiaSorin SpA Management Efficiency

The company has return on total asset (ROA) of 0.0902 % which means that it generated a profit of $0.0902 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.198 %, meaning that it generated $0.198 on every $100 dollars invested by stockholders. DiaSorin SpA's management efficiency ratios could be used to measure how well DiaSorin SpA manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 1.23 B in total debt with debt to equity ratio (D/E) of 3.0, implying the company greatly relies on financing operations through barrowing. DiaSorin SpA has a current ratio of 2.94, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist DiaSorin SpA until it has trouble settling it off, either with new capital or with free cash flow. So, DiaSorin SpA's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like DiaSorin SpA sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for DiaSorin to invest in growth at high rates of return. When we think about DiaSorin SpA's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Catherine BestSuperior Plus Corp
64
Peter KernNorAm Drilling AS
50
David SmithSuperior Plus Corp
59
Douglas HarrisonSuperior Plus Corp
58
Michael KregerNorAm Drilling AS
33
Randall FindlaySuperior Plus Corp
67
Robert EngbloomSuperior Plus Corp
64
Richard BradeenSuperior Plus Corp
61
Mary JordanSuperior Plus Corp
58
Laura WalkerNorAm Drilling AS
60
Ross LevinsohnNorAm Drilling AS
54
Peter MurphyNorAm Drilling AS
55
Eugene BissellSuperior Plus Corp
64
James ArestiaNorAm Drilling AS
N/A
Craig JacobsonNorAm Drilling AS
65
Patrick GottschalkSuperior Plus Corp
54
Walentin MiroshSuperior Plus Corp
71
DiaSorin S.p.A. develops, manufactures, and distributes immunodiagnostics and molecular diagnostics tests for private and hospital analysis laboratories worldwide. DiaSorin S.p.A. was founded in 1968 and is headquartered in Saluggia, Italy. DIASORIN S operates under Diagnostics Research classification in Germany and is traded on Frankfurt Stock Exchange. It employs 1928 people. DiaSorin SpA (34D) is traded on Frankfurt Exchange in Germany and employs 3,313 people.

Management Performance

DiaSorin SpA Leadership Team

Elected by the shareholders, the DiaSorin SpA's board of directors comprises two types of representatives: DiaSorin SpA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of DiaSorin. The board's role is to monitor DiaSorin SpA's management team and ensure that shareholders' interests are well served. DiaSorin SpA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, DiaSorin SpA's outside directors are responsible for providing unbiased perspectives on the board's policies.
Francesca Pasinelli, Independent Director
Vittorio Squarotti, Non-Executive Director
Francesco Colotta, Senior Corporate Vice President and Chief Medical Officer
Riccardo Fava, External Relations Director, Head of Investor Relations and Media
Maria Landini, Non-Executive Director
Giuseppe Alessandria, Lead Independent Director
Roberta Somati, Independent Director
Antonio Boniolo, Non-Executive Director
Gustavo Denegri, Non-Executive Chairman of the Board
Carlo Rosa, CEO, Executive Director, General Manager
Fiorella Altruda, Independent Director
Monica Tardivo, Independent Director
John Eskdale, President DiaSorin Inc
Angelo Rago, Pres Corp
Pier Angelis, CFO, Senior Corporate Vice President Financial Reporting Officer
Ezio Garibaldi, Non-Executive Director
Michele Denegri, Non-Executive Vice Chairman of the Board
Giancarlo Boschetti, Non-Executive Director
Piergiorgio Pedron, Senior Corporate VP and CFO
Ulisse Spada, Mang Department
Tullia Todros, Independent Director
Stefano Ronchi, Senior Corporate Vice President - Human Resources
Eva Desana, Non-Executive Director
Enrico Amo, Non-Executive Director
Stefano Altara, Director
Franco Moscetti, Independent Director
Fabrizio Bonelli, Chief Officer
Ugo Gay, Sr Operations
Chen Even, Senior Corporate Vice President - Commercial Operations and Executive Director

DiaSorin Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is DiaSorin SpA a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Thematic Ideas
Explore Investing Ideas  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in DiaSorin SpA. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Complementary Tools for DiaSorin Stock analysis

When running DiaSorin SpA's price analysis, check to measure DiaSorin SpA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DiaSorin SpA is operating at the current time. Most of DiaSorin SpA's value examination focuses on studying past and present price action to predict the probability of DiaSorin SpA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DiaSorin SpA's price. Additionally, you may evaluate how the addition of DiaSorin SpA to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Please note, there is a significant difference between DiaSorin SpA's value and its price as these two are different measures arrived at by different means. Investors typically determine if DiaSorin SpA is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DiaSorin SpA's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.